Legal scrutiny around Hims & Hers Health, Inc. has widened after Kessler Topaz Meltzer & Check, LLP said it is investigating potential federal securities law violations on behalf of investors who bought the company's securities and suffered significant losses. The new inquiry adds to earlier probes by Berger Montague PC, which said it was examining possible breaches of fiduciary duties by the board, and The Law Offices of Frank R. Cruz, which tied investor claims to a July 29, 2026 FTC lawsuit alleging Hims & Hers engaged in deceptive and unlawful privacy practices by sharing sensitive patient health information with third-party advertisers including Snap and Facebook parent Meta Platforms. Hims shares fell $4.32, or 14.73%, to close at $25.00 on July 29, 2026 after the lawsuit was filed.